Weine Nejdemo
Directeur/Bestuurslid bij Phadia AB
Oorsprong van het eerstegraads netwerk van Weine Nejdemo
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
14
| Public Company | Pharmaceuticals: Generic | 14 |
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.
8
| Subsidiary | Medical Specialties | 8 |
Allergon AB
Allergon AB Pharmaceuticals: MajorHealth Technology Allergon AB develops, manufactures and supplies allergen source materials. The company was founded in 1963 and is headquartered in Ängelholm, Sweden.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Weine Nejdemo via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
POZEN INC. | Pharmaceuticals: Major | Director/Board Member | |
Premier Research Group Ltd.
Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
EffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
ENIRO GROUP AB | Commercial Printing/Forms | Chairman | |
MEDIGENE AG | Biotechnology | Founder | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
ACTIVE BIOTECH AB | Biotechnology | Director/Board Member | |
BIOGAIA AB | Pharmaceuticals: Other | Director of Finance/CFO | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
BioM Biotech Cluster Development GmbH
BioM Biotech Cluster Development GmbH Medical DistributorsDistribution Services BioM AG is a regional technology transfer and venture capital services company created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition. The firm provides business support services to Munich-based biotechnology companies, focusing on startups. Through BioM Biotech Cluster Development GmbH, established in 2006, BioM coordinates the Munich Biotech Cluster, with the objective of turning it into a leading biotechnology center in Europe. They seek to foster an active cooperation between Bavarian research institutions and corporations. BioM actively invests seed capital in biotechnology startups in the Munich area, and manages a venture capital investment fund invested in high-growth early-stage businesses. | Medical Distributors | Chief Executive Officer | |
OREXO AB | Pharmaceuticals: Major | Chairman | |
BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member | |
Stockholm School of Economics | College/University | Graduate Degree Undergraduate Degree | |
University of Uppsala | College/University | Doctorate Degree Undergraduate Degree | |
CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman | |
Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Graduate Degree | |
BioM AG Munich BioTech Development
BioM AG Munich BioTech Development Investment ManagersFinance BioM AG Munich BioTech Development (BMBD) is a venture capital firm specialized in the life sciences sector. Located in Martinsried on the outskirts of Munich, BMBD was established in 2002 to manage the investment portfolio of BioM AG, a regional technology transfer and venture capital services company. BioM was created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition, and provides business support services to Munich-based biotechnology companies, focusing on start-ups. BMBD manages the BioM Venture Capital fund. Their clients include regional banks, German and European private equity firms and private individuals. The firm operates in partnership with public entities, in particular the German Federal Ministry of Education and Research (BMBF) and HighTech Gründerfonds (HTGF), a partnership between the Government of Germany, the KfW banking group and leading technology corporations. | Investment Managers | Chief Executive Officer | |
Ludwig-Maximilians-Universität München | College/University | Corporate Officer/Principal | |
BioCrine AB | Director/Board Member | ||
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
Astra Hässle AB | Chief Executive Officer | ||
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
BIO Deutschland
BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Founder | |
Stockholm Chamber of Commerce
Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Miscellaneous Commercial Services | Director/Board Member | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer | |
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
The Royal Bachelors' Club | Corporate Officer/Principal | ||
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Swedish Academy For Pharmaceutical Sciences | Corporate Officer/Principal | ||
Nicklasson Life Science AB | Corporate Officer/Principal | ||
HP Health Solutions Germany GmbH
HP Health Solutions Germany GmbH Miscellaneous Commercial ServicesCommercial Services GNA Biosolutions GmbH develops instruments for molecular pathogen detection. The firm offers PCA technology, lab and portable solutions. The company was founded by Joachim Stehr, Federico Bürsgens and Lars Ullerich in 2010 and is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Baygene | Chief Tech/Sci/R&D Officer | ||
Switch Biotech AG | Founder | ||
Farma Investment AS
Farma Investment AS Real Estate Investment TrustsFinance Farma Investment AS invests in shares and real properties. The company was founded on June 23, 2011 and is headquartered in Oslo, Norway. | Real Estate Investment Trusts | Chairman | |
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Kenota Health, Inc.
Kenota Health, Inc. Medical SpecialtiesHealth Technology Kenota Health, Inc. designs and develops medical diagnostic tools. The company was founded by Moufeed Kaddoura and Eric Bloudeel in 2014 and is headquartered in Kitchener, Canada. | Medical Specialties | Director/Board Member | |
Council of European Bioregions
Council of European Bioregions Miscellaneous Commercial ServicesCommercial Services The Council of European Bioregions is a membership-based biotechnology organization. The Spanish company was founded by Horst Domdey. | Miscellaneous Commercial Services | Founder | |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
Genome Research Network | Chief Tech/Sci/R&D Officer | ||
Lowell Sverige AB
Lowell Sverige AB Miscellaneous Commercial ServicesCommercial Services Lowell Sverige AB provides debt collection and credit management services. The private company is based in Stockholm, Sweden. The CEO of the Swedish company is Johan Erik Magnus Agerman. | Miscellaneous Commercial Services | Director of Finance/CFO | |
BioGaia Biologics, Inc.
BioGaia Biologics, Inc. Pharmaceuticals: OtherHealth Technology Part of BioGaia AB, BioGaia Biologics, Inc. is a company that develops and sells probiotic products with lactobacillus reuteri. The company was founded in 1990 and is based in Doral, FL. The company's probiotic products have been successful in pediatric, gut health, and oral health. The company has local offices that can be contacted for more information. Biogaia is committed to respecting and protecting their customers' privacy and has a privacy notice that explains how they process personal data. | Pharmaceuticals: Other | Director of Finance/CFO |
Statistieken
Internationaal
Zweden | 27 |
Duitsland | 11 |
Verenigd Koninkrijk | 5 |
Noorwegen | 4 |
Verenigde Staten | 3 |
Sectoraal
Health Technology | 23 |
Commercial Services | 13 |
Consumer Services | 5 |
Finance | 3 |
Distribution Services | 2 |
Operationeel
Director/Board Member | 100 |
Chairman | 36 |
Corporate Officer/Principal | 23 |
Independent Dir/Board Member | 20 |
Chief Executive Officer | 14 |
Sterkste connecties
Insiders | |
---|---|
Joel-Tomas Citron | 32 |
Alf Gunnar Martin Nicklasson | 31 |
Björn Ragnar Björnsson | 29 |
Alexander Kotsinas | 23 |
Peter Jan Sture Ström | 15 |
Daniel L. Peters | 14 |
Horst Domdey | 12 |
Mikael Widell | 7 |
Anders Lundin | 7 |
Dennis M. Flannelly | 6 |
Mikael Asp | 5 |
Jean Forcione | 4 |
Claes Piehl | 3 |
Sofia Rendón Rapp | 3 |
Lasse Veng | 2 |
- Beurs
- Insiders
- Weine Nejdemo
- Bedrijfsconnecties